Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis (scientific article)

Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

Q57751361

Validation of rheumatoid arthritis improvement criteria that include simplified joint counts

Q77430935

Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology

Q24630283

Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years

Q24674079

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

Q27860872

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial

Q33675468

Rheumatoid arthritis-interstitial lung disease-associated mortality.

Q33744934

A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis

Q33982255

Toward improved statistical methods for analyzing Cotinine-Biomarker health association data

Q34038971

Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis

Q34187692

Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis

Q34515105

Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides

Q34569421

Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study

Q34604666

Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry

Q35025293

Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis.

Q35637122

Early rheumatoid arthritis in African-Americans: the CLEAR Registry.

Q35669653

Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis

Q35759985

Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women

Q36496352

Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis

Q37157486

Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis.

Q37318673

Predictors of infection in rheumatoid arthritis

Q40629895

Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts

Q42621920

A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination

Q42676934

Anti-TNF-alpha agents are less effective for the treatment of rheumatoid arthritis in current smokers

Q43201741

The association of race and ethnicity with disease expression in male US veterans with rheumatoid arthritis.

Q45332309

Relationship between pack-year history of smoking and response to tumor necrosis factor antagonists in patients with rheumatoid arthritis

Q47784100

Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial.

Q51528833

High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis.

Q51824341

Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure.

Q52267425

Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group.

Q52919247

Progressive preclinical interstitial lung disease in rheumatoid arthritis.

Q53438843

Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatolog

Q57224416

P433

issue

P921

main subject

rheumatoid arthritis

Q187255

biomarker

Q864574

P304

page(s)

1804-1810

P577

publication date

2012-12-01

P1433

published in

Arthritis Care and Research

Q15754720

P1476

title

Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis

P478

volume

Reverse relations

cites work (P2860)

Q37013908	Cigarette smoking and musculoskeletal disorders
Q36960366	Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial.
Q42602569	Detection of Serum microRNAs From Department of Defense Serum Repository: Correlation With Cotinine, Cytokine, and Polycyclic Aromatic Hydrocarbon Levels
Q36302246	Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?
Q38241734	Impact of smoking on response to systemic treatment in patients with psoriasis: a retrospective case-control study
Q42726419	Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: a cross-sectional analysis of US veterans.
Q38958301	Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study